Fig. 4.
Association between clinical outcomes and anti-SARS-CoV-2 neutralizing or commercial antibodies. (A) Death. (B) Intubation. (C) Cardiac injury. (D) Acute kidney injury. Data from 34 patients with PCR-positive COVID-19. Solid horizontal line represents the mean. * P < 0.05.

Association between clinical outcomes and anti-SARS-CoV-2 neutralizing or commercial antibodies. (A) Death. (B) Intubation. (C) Cardiac injury. (D) Acute kidney injury. Data from 34 patients with PCR-positive COVID-19. Solid horizontal line represents the mean. * P < 0.05.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close